Current Burden of Hepatitis B Virus Infection in the United States, 2017–2023

Clinical and Molecular Hepatology · Published 2026-07-23 · DOI 10.3350/cmh.2026.0817

Free full text

Authors (4)

Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, Aijaz Ahmed

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kim, D., Danpanichkul, P., Wijarnpreecha, K., et al. (2026). Current Burden of Hepatitis B Virus Infection in the United States, 2017–2023. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0817

Related articles

• Targeting ER lipid raft-associated 1 reveals a coordinated cholesterol-dependent vulnerability in hepatocellular carcinoma · Clinical and Molecular Hepatology · 2026 · Same journal
• Noncanonical EZH2 activity cooperates with FOXM1 to drive tumorigenesis and advanced progression in HCC · Clinical and Molecular Hepatology · 2026 · Same journal
• Viral load rather than transaminase: an international perspective on the KASL–EALA 2026 guideline for chronic hepatitis B · Clinical and Molecular Hepatology · 2026 · Same journal
• Genetic and Genomic Insights Across the SLD Spectrum · Clinical and Molecular Hepatology · 2026 · Same journal
• Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study · Clinical and Molecular Hepatology · 2026 · Same journal
• Emerging therapeutic regimens as alternatives to glucocorticoids for severe alcohol-associated hepatitis: a comprehensive review · Clinical and Molecular Hepatology · 2026 · Same journal
• Rethinking lean metabolic dysfunction-associated steatotic liver disease: Unrecognized risk in lean populations: Editorial on “Normal-weight metabolic dysfunction-associated steatotic liver disease: Reclassification, characteristics, and adverse liver outcomes across diverse populations” · Clinical and Molecular Hepatology · 2026 · Same journal
• Oncofetal reprogramming in hepatocellular carcinoma: linking developmental programs to cancer vaccines and immunotherapy · Clinical and Molecular Hepatology · 2026 · Same journal
• Interleukin-1β as target to induce synthetic lethality in KRAS mutant biliary tract cancer · Clinical and Molecular Hepatology · 2026 · Same journal
• Artificial Intelligence and Generative Models in Hepatology: From Large Language Models to Digital Pathology in Liver Disease Diagnosis and Treatment · Clinical and Molecular Hepatology · 2026 · Same journal